J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations
Launched by UNIVERSITY OF CHICAGO · Jun 21, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The J-RISE clinical trial is studying two different support programs aimed at helping Black men who have been involved with the criminal justice system access HIV care and employment services. The goal is to see if the "Health Navigation Plus" program, which includes extra job support and financial help, can help participants find jobs and access important health services better than the standard "Health Navigation" program.
To participate, individuals must be at least 18 years old, identify as African American or Black, and have had some involvement with the criminal legal system. They also need to be living in specific areas like Cook County, Illinois, New Orleans, or Baton Rouge. Participants will be randomly assigned to one of the two programs and will complete surveys over 13 months. Those in the Health Navigation Plus group will receive additional support for job placement and financial assistance, while both groups will have regular check-ins with health navigators. It's a chance for eligible individuals to gain valuable resources for their health and employment needs.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. be at least 18 years of age;
- • 2. currently reside or intend to reside in one of the study communities (i.e., Cook County, Baton Rouge, and the New Orleans area);
- 3. be able to provide informed consent in English and complete the study in English. In addition, potential participants must:
- • 4. be currently incarcerated in jail or prison and report an expected release within 90 days, or under community supervision or drug court, or report a recent incarceration within the last three years, or in the last 12 months has had an interaction with law enforcement that did not lead to an arrest or jail or prison time, AND has not already been linked and/or retained in HIV or PrEP care in the community;
- • 5. report needing employment-related services; and
- • 6. have a confirmed HIV positive or negative status (within 90 days of enrollment) and if HIV negative meets one of CDC's PrEP indications (i.e., sexually active, needle sharing, previous STI history in the last 24 months) or plans to have sex in the next 12 months or wants more information about PrEP.
- Exclusion Criteria:
- • 1. unwilling/unable to provide informed consent,
- • 2. does not live or intend to live in one of the study locations,
- • 3. unable to confirm HIV status,
- • 4. unable to conduct the study in English, and
- • 5. currently enrolled in another intervention to support HIV care, PrEP care, and economic stability.
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Russell Brewer, DrPH
Principal Investigator
University of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported